Presented at the recent ESC meeting 2008, the Trial of Intensified vs. Standard Medical Therapy in Elderly Patients with Congestive Heart Failure (TIME-CHF) showed that the use of natriuretic-peptide levels rather than symptoms alone to guide the medical management of heart failure failed to influence the primary endpoint of hospitalisation-free survival over 18 months.
